Secondary Logo

Journal Logo

March 28, 2003 - Volume 17 - Issue 5
pp: 645-790


A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy

Lalezari, Jacob P; Eron, Joseph J; Carlson, Margrit; More

AIDS. 17(5):691-698, March 28, 2003.


Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

Myers, Robert P; Benhamou, Yves; Imbert-Bismut, Françoise; More

AIDS. 17(5):721-725, March 28, 2003.

Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy

Mazeron, Marie-Christine; Fillet, Anne-Marie; Salmon, Dominique; More

AIDS. 17(5):784-786, March 28, 2003.